Amarin Statistics
NASDAQ: AMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.57-0.69 (-6.13%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Amarin by the numbers
Amarin has a market capitalization of $444.4 million based on 42.04M shares outstanding. With trailing EPS of $-0.80, Amarin is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.7% below its 50-day average and 24.7% below its 200-day average.
Average daily trading volume is 79.50K shares, or about $840,315 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMRN valuation vs. peer median
| Metric | AMRN | Peer median | Difference |
|---|---|---|---|
| Market cap | $444.39M | $443.85M | +0% |
| Avg. volume | 79.50K | 753.78K | -89% |
Peer median across 8 companies: DMAC, CTMX, KMDA, LYEL, CAPR, AQST, STTK, ASMB.
Valuation
- Market cap
- $444.39M
- Forward P/E
- 10.79
- Price / sales (latest FY)
- 2.08
- EPS (TTM)
- $-0.80
- Shares outstanding
- 42.04M
Price and trading
- Previous close
- 11.26
- Open
- 11.26
- Day range
- 10.56 – 11.30
- 52-week range
- 10.56 – 17.31
- 52-week change
- -35.47%
- Beta
- —
- Volume
- 177.91K
- Average volume
- 79.50K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 444.39M
- Forward Pe
- 10.79
- Eps
- -0.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.31
- Week52 Low
- 10.56
- Avg Volume
- 79,500.00
- Shares Outstanding
- 42.04M
- Ma50
- 12.24
- Ma200
- 14.04
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -38.94%
- Pct From52w Low
- 0.14%